Internet-CBT for Gambling Disorder - a Randomized Controlled Trial
- Conditions
- Gambling Disorder
- Interventions
- Behavioral: Internet-based cognitive behavioral therapy (iCBT)
- Registration Number
- NCT06099522
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
The study is a randomized controlled trial (Total N=150; each condition n=75) of internet-based cognitive behavioral therapy (iCBT), with measures at pre, weekly during treatment, post, three and at six month follow-up. Participants will be assigned to either standard iCBT and "Spelpaus" (treatment condition), or "Spelpaus" only (control condition).
- Detailed Description
Recruitment will be done through online advertisement via social media and gambling-related websites. Participants will self-referred to the study via a study dedicated website (www.spelstudien.se). Login to a treatment platform will be verified using double authentication (detailed description of the online platform is provided in the application to the Swedish Ethical Review Authority). Written information about the study will be provided on the web page. Consent will be done online, with the possibility for participants to download study information and consent. Consenting participants will start a screening procedure. After screening, participants will be contacted for a telephone assessment with a clinical psychologist. During this interview, participants will be assessed for GD with a diagnostic interview, as well as the inclusion criteria for utilization of "Spelpaus". If meeting criteria for the study, participants will be referred to the baseline/pre-measures - which will start with an additional informed consent for the treatment phase and the iCBT. Inclusion will be done after the completion of the informed consent and baseline/pre-measures. After that, participant will be randomized to iCBT and "Spelpaus" (treatment condition), or "Spelpaus" only (control condition). Randomization will be conducted by a third party using a true random service, https://random.org. Participants assigned to the control condition in the randomized controlled trial will receive a voucher of total 1000 Swedish Krona's when completing the post and follow up measures. Participants assigned to the control condition in the randomized controlled trial will receive a voucher of total 1000 Swedish Krona's when completing the post and follow up measures.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- Screen positive for GD, as measured with the Gambling Disorder Identification Test (total score ≥20 GDIT).
- Fulfilling GD, assessed according to the Structured Clinical Interview for Gambling Disorder (SCI-GD).
- Utilization of "Spelpaus", 3 months from treatment start.
- ≥18 years of age.
- Able to provide digital informed consent.
- Other ongoing psychological treatment for GD.
- Severe depression, screened according to the Montgomery Åsberg Depression Rating Scale (total score >34 MADRS-S).
- Suicidality, screening of ≥4 points on item 9 of the MADRS-S
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Internet-based cognitive behavioral therapy (iCBT) Internet-based cognitive behavioral therapy (iCBT) An 8-module internet-delivered cognitive behavioral therapy program. Participants receiving treatment will simultaneously use "Spelpaus" - a self-exclusion gambling service.
- Primary Outcome Measures
Name Time Method The Gambling Symptom Assessment Scale 6 month after treatment cessation Primary outcome will be gambling symptoms, measured with the the Gambling Symptom Assessment Scale. Minimum score is 0 and maximum score is 48, with higher scores indicated higher frequency of gambling symptoms.
- Secondary Outcome Measures
Name Time Method The TimeLine Followback for gambling 6 month after treatment cessation Gambling behavior (days per week gambled) will be measured with a self-report item adapted from the TimeLine Followback for gambling.
The Generalized Anxiety Disorder 7-itemscale 6 month after treatment cessation Anxiety symptoms will be measured by the Generalized Anxiety Disorder 7-itemscale.
The Patient Health Questionnaire 6 month after treatment cessation Depressive symptoms will be measured with the The Patient Health Questionnaire.
The Drug Use Disorders Identification Test 6 month after treatment cessation Drug problems will be measured with the Drug Use Disorders Identification Test.
The Alcohol Use Disorders Identification Test 6 month after treatment cessation Alcohol problems will be measured with the Alcohol Use Disorders Identification Test.
Trial Locations
- Locations (1)
Centre for psychiatry research
🇸🇪Stockholm, Sweden